Abbott Enters Electrophysiology Fray With Topera, ACT Deals
This article was originally published in The Gray Sheet
Executive Summary
The diversified company is entering the atrial fibrillation catheter ablation for the first time. It is acquiring Afib ablation mapping system maker Topera and has gained rights to buy catheter developer Advanced Cardiac Therapeutics.